4 Steps to Accelerate Speed-to-Market in Life Sciences Manufacturing

Life sciences companies face growing pressure to accelerate speed-to-market while managing complex global operations and safeguarding compliance. The key to overcoming these challenges lies in trusted, standardized data. By establishing the AVEVA PI System as a single source of truth, organizations can eliminate legacy data bottlenecks, unify siloed operational inputs, and accelerate regulatory reviews.

Digitize Once, Validate Less: Eliminate downtime and manual re-validation by modernizing legacy historians and standardizing data directly at the source.
Unify Every Input: Connect process, lab, and utility data into a single contextualized framework to give operators real-time, actionable insights.
Embed Audit-Ready Traceability: Cut compliance reporting times by up to 50% with time-synced, transparent records that build immediate trust with regulators and CDMO partners.
Preserve Momentum in Handoffs: Eliminate delays during technology transfer from lab to commercial scale using review-by-exception and multivariate batch analytics.

Download the full white paper “Trusted Inputs, Vital Impacts” to see how leaders like Genentech, BMS, and Biogen use AVEVA PI System to bring life-saving therapies to market faster.

White Paper from

Complete the form below to download the content:

Answer the following questions about your organization below:

AVEVA would like to contact you in the future on their products and services via phone, email, and/or post. For more details on our information practices and how to unsubscribe, please see their Privacy Policy. You can unsubscribe at any time.

You have been directed to this site by Global IT Research. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.

If your Download does not start Automatically, Click Download Whitepaper